154 related articles for article (PubMed ID: 26859371)
1. Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.
Rossi C; Cox J; Cooper C; Martel-Laferrière V; Walmsley S; Gill J; Sapir-Pichhadze R; Moodie EE; Klein MB;
AIDS; 2016 Jun; 30(9):1403-311. PubMed ID: 26859371
[TBL] [Abstract][Full Text] [Related]
2. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV.
Young J; Rossi C; Gill J; Walmsley S; Cooper C; Cox J; Martel-Laferriere V; Conway B; Pick N; Vachon ML; Klein MB;
Clin Infect Dis; 2017 May; 64(9):1154-1162. PubMed ID: 28199495
[TBL] [Abstract][Full Text] [Related]
5. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
6. Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals.
Nitulescu R; Young J; Saeed S; Cooper C; Cox J; Martel-Laferriere V; Hull M; Walmsley S; Tyndall M; Wong A; Klein MB;
Int J Drug Policy; 2019 Mar; 65():41-49. PubMed ID: 30594080
[TBL] [Abstract][Full Text] [Related]
7. Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.
Hayashi K; Milloy MJ; Wood E; Dong H; Montaner JS; Kerr T
J Int AIDS Soc; 2014; 17(1):19296. PubMed ID: 25391765
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.
Meijide H; Pértega S; Rodríguez-Osorio I; Castro-Iglesias Á; Baliñas J; Rodríguez-Martínez G; Mena Á; Poveda E
AIDS; 2017 May; 31(8):1099-1107. PubMed ID: 28441174
[TBL] [Abstract][Full Text] [Related]
9. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
10. Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection.
Moqueet N; Cooper C; Gill J; Hull M; Platt RW; Klein MB;
J Infect Dis; 2016 Jul; 214(1):80-6. PubMed ID: 26984148
[TBL] [Abstract][Full Text] [Related]
11. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.
Rossi C; Saeed S; Cox J; Vachon ML; Martel-Laferrière V; Walmsley SL; Cooper C; Gill MJ; Hull M; Moodie EEM; Klein MB;
AIDS; 2018 Mar; 32(6):751-759. PubMed ID: 29369156
[TBL] [Abstract][Full Text] [Related]
13. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
[TBL] [Abstract][Full Text] [Related]
14. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
[TBL] [Abstract][Full Text] [Related]
15. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
[TBL] [Abstract][Full Text] [Related]
16. Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up.
Kronfli N; Bhatnagar SR; Hull MW; Moodie EEM; Cox J; Walmsley S; Gill J; Cooper C; Martel-Laferrière V; Pick N; Klein MB;
AIDS; 2019 May; 33(6):1013-1022. PubMed ID: 30946155
[TBL] [Abstract][Full Text] [Related]
17. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
[TBL] [Abstract][Full Text] [Related]
18. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
[TBL] [Abstract][Full Text] [Related]
19. Kidney diseases in HIV/HCV-co-infected patients.
Izzedine H; Sene D; Cacoub P; Jansen H; Camous L; Brocheriou I; Bourry E; Deray G
AIDS; 2009 Jun; 23(10):1219-26. PubMed ID: 19440143
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
